A method of potentiating an immune response against a cancer, non-cancerous tumor or both in a patient is provided. The method includes administering splenocytes harvested from all or a part of a patients spleen. The splenocytes can be administered in combination with a biological response modifier to potentiate an immune response against a cancer, non-cancerous tumor or both in a patient.
